• Publications
  • Influence
Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
TP63 is required to maintain stem cell pluripotency and suppresses the metastatic potential of cancer cells through multiple mechanisms. These functions are differentially regulated by individualExpand
  • 13
  • 2
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
Epigenetic modifiers frequently harbor loss-of-function mutations in lung cancer, but their tumor-suppressive roles are poorly characterized. Histone methyltransferase KMT2D (a COMPASS-like enzyme,Expand
  • 8
  • 1
  • PDF
TAp63-Regulated miRNAs Suppress Cutaneous Squamous Cell Carcinoma through Inhibition of a Network of Cell-Cycle Genes
This study provides preclinical evidence for the use of miR-30c-2*/miR-497 delivery and AURKA inhibition in the treatment of cuSCC, which currently has no FDA-approved targeted therapies. TAp63 is aExpand
  • 1
  • 1
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.
The primary mechanisms supporting immunoregulatory polarization of myeloid cells upon infiltration into tumors remain largely unexplored. Elucidation of these signals could enable better strategiesExpand
  • 7
Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism
TAp63, a member of the p53 family, has been shown to regulate energy metabolism. Here, we report coiled coil domain-containing 3 (CCDC3) as a new TAp63 target. TAp63, but not ΔNp63, p53 or p73,Expand
  • 6
AMPK alpha-1 intrinsically regulates the function and differentiation of tumor myeloid-derived suppressor cells.
Myeloid-derived suppressor cells (MDSC) represent a primary mechanism of immune evasion in tumors and have emerged as a major obstacle for cancer immunotherapy. The immunoinhibitory activity of MDSCExpand
  • 8
p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming
The generation of induced pluripotent stem cells (iPSCs) by somatic cell reprogramming holds great potential for modeling human diseases. However, the reprogramming process remains very inefficientExpand
  • 12
  • PDF
The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer
ABSTRACT The tumour suppressor p53 and its paralogues, p63 and p73, are essential to maintain cellular homoeostasis and the integrity of the cell’s genetic material, thus meriting the title ofExpand
  • 3
The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss
Undifferentiated embryonal sarcoma of the liver (UESL) is a rare and aggressive malignancy. Though the molecular underpinnings of this cancer have been largely unexplored, recurrent chromosomalExpand
  • 4
  • PDF
p53 Family Members: p63 and p73
Almost two decades subsequent to the discovery of p53, two homologues p63 and p73 were revealed. Much excitement erupted in the p53 field due to the fact that these genes bear significant homology toExpand
  • 3